Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 4/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 10/20 | 0.44 |
| ▸ | CA2 | P00918 | 10/20 | 0.44 |
| ▸ | CA9 | Q16790 | 4/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
| ▸ | PPIA | P62937 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14546320 | 0.85 | ATM (0.49) | ATMMEN1KMT2AUSP2MAPT | |
| SCHEMBL10508151 | 0.84 | ATM (0.48) | ATMMEN1KMT2AUSP2MAPT | |
| SCHEMBL10507989 | 0.83 | MEN1 (0.49) | ATMMEN1KMT2AUSP2MAPT | |
| SCHEMBL5311223 | 0.80 | ATM (0.56) | ATMMEN1KMT2AUSP2MAPT | |
| SCHEMBL8657856 | 0.79 | KMT2A (0.59) | ATMMEN1KMT2AMAPTHTT | |
| SCHEMBL14546321 | 0.78 | KMT2A (0.49) | ATMMEN1KMT2AUSP2MAPT | |
| SCHEMBL6509510 | 0.78 | ATM (0.52) | ATMMEN1KMT2AUSP2MAPT | |
| SCHEMBL10507936 | 0.77 | KMT2A (0.48) | ATMMEN1KMT2AUSP2MAPT | |
| SCHEMBL8658188 | 0.77 | MEN1 (0.56) | ATMMEN1KMT2AUSP2MAPT | |
| SCHEMBL8660904 | 0.77 | KMT2A (0.64) | ATMMEN1KMT2AUSP2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050159599-A1 | Cyclic compound, process for producing the same, and pest control agent | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-07-21 | — | — | US | disclosed |
| EP-1481972-A1 | CYCLIC COMPOUND, PROCESS FOR PRODUCING THE SAME, AND PEST CONTROL AGENT | Sumitomo Chemical Takeda Agro Company, Limited (JP) | 2004-12-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050159599-A1 | Cyclic compound, process for producing the same, and pest control agent | CNPY2, CNPY3, HAX1 | ATM 2564/4885MEN1 2593/4885KMT2A 1362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.